ONEMEDNET CORPORATION Financial and Nonfinancial Liabilities, Fair Value Disclosure
ONEMEDNET CORPORATION (ONMD) had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $24.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2026-08-14
- 2026-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $24.00K.
- 2026-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $129.00K.
- 2025-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $257.00K.
- 2025-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $440.00K.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $24.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $129.00K S-1/A · filed 2026-07-08 |
| 2025-12-31 | $257.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $440.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $18.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $2.32M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $3.90M S-1/A · filed 2026-07-08 |
| 2024-09-30 | $3.53M 10-Q · filed 2024-12-17 |
| 2024-06-30 | $4.03M 10-Q · filed 2024-12-11 |
| 2024-03-31 | $1.63M 10-Q · filed 2024-12-05 |
| 2023-12-31 | $1.66M 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |